Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 2 5Phase 1/2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 17Sarcoma 10Genitourinary 6Gynecologic 5CNS 3Thoracic 2Plasma cell 2Other hematologic neoplasm 2Other solid neoplasm 1Other neoplasm 1Myeloid 1Gastrointestinal 1Dermatologic 1Classical hematology 1Breast 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 1

Interventions

pembrolizumab 120Carboplatin 114Pemetrexed 74Cisplatin 71Nivolumab 68Paclitaxel 58Docetaxel 56Radiotherapy 41Erlotinib Hydrochloride 41Gemcitabine 35Etoposide 34atezolizumab 30osimertinib 29Cetuximab 27Ipilimumab 25Bevacizumab 25Radiosurgery 22durvalumab 21Cyclophosphamide 20Drug Therapy 18130-nm albumin-bound paclitaxel 17avelumab 14Taxes 14Gefitinib 14Albumin-Bound Paclitaxel 14Irinotecan 13Injections 13fludarabine 11Radiation 11cemiplimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Ifosfamide × Thoracic × Clear all
NCT01784107 2016-02-10

A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer

Gachon University Gil Medical Center

Phase 1/2 Unknown
45 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00004186 2013-04-12

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 1/2 Completed
55 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡